Glucose oxidation in alveolar macrophages: pharmacologic features.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000096:biosynthesis*; D002250:Carbon Radioisotopes; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D010587:Phagocytosis / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000166:cytology* / Q000187:drug effects; D011817:Rabbits; D013210:Staphylococcus / Q000378:metabolism; D013566:Sympathomimetics / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D011453:Prostaglandins; D013566:Sympathomimetics; D002245:Carbon Dioxide; D003994:Bucladesine; D011433:Propranolol; D013806:Theophylline; D005947:Glucose; D007545:Isoproterenol; D004837:Epinephrine